Skip to content

FP7H2020

MAX IV Laboratory, Lund University

Country
SESweden
Defence projects
0
Projects, all programmes
257
As coordinator
74
EU contribution (CORDIS)
EUR 111,094,598
Active
2008 to 2016

Projects

257 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
CORNUCOPIAYeast biodiversity as a source of innovations in food and healthFP72011CoordinatorEUR 746,702
TREATPOLYQTreatPolyQ – Industrial Academic Initial Training Network towards treatment of Polyglutamine DiseasesFP72011ParticipantEUR 260,042
SPREADSocial Platform identifying Research and Policy needs for Sustainable LifestylesFP72011ParticipantEUR 92,234
EJOLTEnvironmental Justice Organizations, Liabilities and TradeFP72011ParticipantEUR 110,608
GENE TARGET T2DGeneral and targeted approaches to unravel the molecular causes of type 2 diabetesFP72011CoordinatorEUR 2,499,480
PRACE-2IPPRACE - Second Implementation Phase ProjectFP72011ParticipantEUR 50,329
FOOD4MEPersonalised nutrition: An integrated analysis of opportunities and challengesFP72011ParticipantEUR 244,312
INGOSIntegrated non-CO2 Greenhouse gas Observing SystemFP72011ParticipantEUR 177,588
PAGE21Changing Permafrost in the Arctic and its Global Effects in the 21st CenturyFP72011ParticipantEUR 353,160
Alien SpeciesBiological Invasions in Marine Ecosystems – the Role of Phenotypic PlasticityFP72011CoordinatorEUR 45,000
PANACREASIntegrating chemical approaches to treat pancreatic cancer: making new leads for a cureFP72011ParticipantEUR 280,720
Goal-LeadersGoal-directed, Adaptive Builder RobotsFP72011ParticipantEUR 388,715
EPIXCHANGEInnovative gene therapies for epilepsy treatmentFP72011ParticipantEUR 371,544
UBIQCANCERTHE ROLE OF UBIQUITYLATION AND DEUBIQUITINATION ENZYMES IN CANCERFP72011CoordinatorEUR 1,067,280
CONPHIRMERCounterfeit Pharmaceuticals Interception using Radiofrequency Methods in RealtimeFP72011ParticipantEUR 493,500
EINSNetwork of Excellence in Internet ScienceFP72011ParticipantEUR 5,280
MITOCARETreatment of reperfusion injury using a mitochondrial targeted approach: towards a better understanding of the diseaseFP72011ParticipantEUR 413,120
PRISTINE-PDPrion-like transmission of α-synuclein in Parkinson's diseaseFP72011CoordinatorEUR 2,499,998
STAY OR GOPartial migration: individual causes and population genetic consequencesFP72011CoordinatorEUR 193,766
LACOLALanguage, cognition and landscape: understanding cross-cultural and individual variation in geographical ontologyFP72011CoordinatorEUR 1,499,931

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.